MustGrow Biologics (TSE:MGRO) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MustGrow Biologics Corp. has announced a significant grant of equity incentives, including deferred share units (DSUs) and restricted share units (RSUs), to its directors, officers, and consultants. The grant aims to align the interests of key MustGrow personnel with those of the company and its shareholders, and the incentives will vest upon cessation of their positions. MustGrow is actively developing organic biocontrol and biofertility products, collaborating with major global partners to replace harmful synthetic chemicals in agriculture.
For further insights into TSE:MGRO stock, check out TipRanks’ Stock Analysis page.